mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.0024 |
1 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.0031 |
1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |